ELV Elevance Health, Inc.
Hospital & Medical Service Plans · NYSE · SEC CIK 1156039 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $51.43B | $50.47B | $50.18B | $49.75B | $50.71B | $49.78B | $48.89B | $45.44B |
| Cost of revenue | $5.64B | $5.49B | $5.46B | $5.52B | $5.38B | $5.29B | $4.98B | $6.01B |
| SG&A expense | $5.75B | $5.55B | $6.33B | $5.42B | $5.27B | $5.00B | $5.30B | $4.80B |
| Operating income | $1.27B | $1.76B | $2.09B | $309.00M | $1.29B | $2.42B | $3.17B | $673.00M |
| Interest expense | $358.00M | $364.00M | $357.00M | $366.00M | $351.00M | $341.00M | $344.00M | $340.00M |
| Pretax income | $1.79B | $1.94B | $2.30B | $215.00M | $1.41B | $2.29B | $2.80B | $606.00M |
| Income tax | $451.00M | $483.00M | $544.00M | -$331.00M | $219.00M | $548.00M | $613.00M | $193.00M |
| Net income | $1.36B | $1.46B | $1.76B | $547.00M | $1.19B | $1.74B | $2.18B | $418.00M |
| EBITDA | $1.63B | $2.13B | $2.44B | $715.00M | $1.68B | $2.81B | $3.54B | $1.07B |
| EPS (basic) | 6.30 | 6.74 | 8.03 | — | 5.32 | 7.74 | 9.64 | — |
| EPS (diluted) | 6.27 | 6.71 | 8.00 | — | 5.32 | 7.72 | 9.61 | — |
| Dividends declared per share | 1.72 | 1.72 | 1.72 | 1.71 | 1.71 | 1.71 | 1.71 | 1.63 |
| Weighted avg. shares (diluted) | 217.60M | 217.90M | 220.40M | — | 223.70M | 225.80M | 227.20M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $10.35B | $10.23B | $9.66B | $9.49B | $8.71B | $8.56B | $7.50B | $8.29B |
| Short-term investments | $25.35B | $25.72B | $25.91B | $25.88B | $26.28B | $25.30B | $25.44B | $25.20B |
| Current assets | $68.52B | $67.18B | $67.03B | $63.00B | $63.78B | $63.32B | $61.12B | $58.94B |
| PP&E, net | $4.61B | $4.64B | $4.66B | $4.68B | $4.66B | $4.64B | $4.62B | $4.65B |
| Goodwill | $28.34B | $28.34B | $28.34B | $28.34B | $28.45B | $28.37B | $28.42B | $28.28B |
| Intangibles | $10.88B | $10.98B | $11.09B | $11.20B | $11.33B | $11.49B | $11.94B | $12.09B |
| Total assets | $127.80B | $126.44B | $125.83B | $121.49B | $122.75B | $121.94B | $119.72B | $116.89B |
| Current liabilities | $46.66B | $44.25B | $45.31B | $41.03B | $40.88B | $43.83B | $42.70B | $40.58B |
| Short-term debt | $375.00M | $375.00M | $350.00M | $1.10B | $749.00M | $1.65B | $1.64B | $1.65B |
| Long-term debt | $30.38B | $30.67B | $30.77B | $30.80B | $31.17B | $28.18B | $28.11B | $29.22B |
| Total debt | $30.76B | $31.04B | $31.12B | $31.90B | $31.92B | $29.83B | $29.75B | $30.87B |
| Total liabilities | $83.01B | $81.42B | $81.78B | $77.47B | $78.67B | $78.09B | $77.10B | $75.46B |
| Shareholders' equity | $44.68B | $44.88B | $43.90B | $43.88B | $43.95B | $43.72B | $42.50B | $41.31B |
| Net debt | $20.41B | $20.81B | $21.46B | $22.41B | $23.21B | $21.27B | $22.25B | $22.58B |
| Shares outstanding | 216.11M | 216.84M | 217.37M | 220.72M | 222.04M | 224.84M | 225.64M | 227.48M |
| Cash flow statement | ||||||||
| Operating cash flow | $1.27B | $1.91B | $4.33B | $84.00M | $1.14B | $2.05B | $1.02B | $706.00M |
| Capital expenditure | $267.00M | $287.00M | $235.00M | $293.00M | $360.00M | $267.00M | $196.00M | $322.00M |
| Free cash flow | $1.00B | $1.63B | $4.10B | -$209.00M | $775.00M | $1.79B | $821.00M | $384.00M |
| Investing cash flow | -$1.99B | $159.00M | -$1.64B | $464.00M | -$1.22B | -$687.00M | $103.00M | -$1.64B |
| Financing cash flow | $838.00M | -$1.49B | -$2.52B | $236.00M | $243.00M | -$308.00M | -$1.91B | $1.41B |
| Depreciation & amortization | $363.00M | $366.00M | $354.00M | $406.00M | $387.00M | $380.00M | $373.00M | $398.00M |
| Stock-based compensation | $80.00M | $75.00M | $55.00M | $30.00M | $84.00M | $81.00M | $81.00M | -$29.00M |
| Dividends paid | $373.00M | $373.00M | $376.00M | $377.00M | $381.00M | $385.00M | $386.00M | $373.00M |
| Share buybacks | $330.00M | $234.00M | $1.12B | $471.00M | $876.00M | $378.00M | $880.00M | $1.81B |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.